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Abstract 
 Hippocampus trimaculatus are highly valued and the most heavily traded seahorse species for traditional medicine purposes 
in many Asian countries. One of the main interesting features in H.trimaculatus is their richness in protein which can be 
hydrolyzed into bioactive peptides. In the previous study, H. trimaculatus was hydrolyzed using commercial enzymes, the 
peptides responsible for neuroprotective activity was identified as HTP-1. In the present study, in vitro co-culture system of 
neuronal (PC12) cells and Aβ42 oligomer-stimulated murine microglia cells (BV2 cells) were used to test neuroprotective effects 
of HTP-1. The co-culture system showed that HTP-1 protected PC12 cells from BV2 neurotoxic responses. In addition, the 
activation of PI3K/Akt signaling pathway by HTP-1 were confirmed. The PI3K/Akt activation was found to be mediated through 
transforming growth factor-β (TGF-β) induction by HTP-1. Furthermore, this signaling pathway was found to up-regulate the 
expression of pro survival protein expression in PC12 cells. Collectively, HTP-1 has potent protective effect against neuronal 
cells death in in vitro model of Alzheimer’s disease.  
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1. Introduction 
    Alzheimer’s diseases (AD) is an age-dependent neurodegenerative disease that results in progressive loss of 
cognitive function. It is characterized by the accumulation of Aβ into amyloid plaques in the extracellular brain 
parenchyma and the formation of tangles inside neurons as a result of abnormal phosphorylation of the 
microtubuleassociated protein tau1,2. The major species in Aβ production are the Aβ40 and Aβ42, with Aβ42 being 
predominant in neuritic plaques of AD patients and showing a higher in vitro propensity to aggregate and form 
amyloid fibrils. Given the pathological significance of the Aβ42, determining its effect on central nervous system 
(CNS) seems to be important for developing therapeutic AD agents3.  
    Recently, it was reported that microglia play an opposing roles in AD pathogenesis4. Not only eliminate Aβ 
aggregates via phagocytosis, they also kill adjacent neurons by causing inflammation and the release of neurotoxic 
substances5,6. Virtually, activated microglia secretes a host of soluble factors such as glia-derived neurotrophic factor 
which are potentially beneficial to the neuron survival. However, the majority of factors produced by activated 
microglia are neurotoxic7. The factors include free radicals such as reactive oxygen species (ROS) and nitric oxide 
(NO), inflammatory mediators such as prostaglandin E2 (PGE2), cytokines  such as tumor necrosis factor-α (TNF-α), 
interleukin-6 (IL-6) and interleukin-1β (IL-1β)8. In vitro and in vivo models have demonstrated that excessive 
quantities of individual factors produced by activated microglia can be deleterious to neurons.  Individual factors 
often work in concert to induce neurodegeneration9. Even though neuronal cells are among the longest living cell 
types in mammals, unlike many other cells, they have a limited capacity for self-repair in response to injury. For this 
reason, there is an obvious interest in limiting the cell damage caused by various insults that trigger endogenous 
repair mechanisms10.  
    Conditioned medium from activated microglia has been continuously demonstrated to induce neuronal apoptosis 
via secretion of neurotoxic factor11. Therefore, co-culture of Aβ42-stimulated BV2 cells with PC12 cells will be an 
excellent model to study in vitro model of AD. In our previous study, we have successfully isolated 
neuroprotectivepeptide (HTP-1) derived from seahorse Hippocampus trimaculatus. The HTP-1 sequence was 
identified as Gly-Thr-Glu-Asp-Glu-Leu-Asp-Lys (906.4 Da) (Fig. 1)12. In an effort to further investigate 
neuroprotective effect of HTP-1, in this study we used an in vitro AD model approach that used co-culture of Aβ42-
stimulated murine microglia BV2 cells and PC12 neuron cultures. 
 
 
Fig. 1.Amino acid sequence of HTP-1 
 
Nomenclature 
HTP-1  neuroprotective peptide derived from seahorse Hippocampus trimaculatus 
PC12  a cell line derived from a pheochromocytoma of the rat adrenal medulla 
BV2  murine microglia cells 
Aβ42  the 42 amino acid form of β amyloid  
Co-culture the growth of more than one distinct cell type in a combined culture 
p53  tumor protein p53 
p50  Nuclear factor kappa beta p50 subunit 
p65  Nuclear factor kappa beta p65 subunit 
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2. Materials and methods  
2.1. Materials 
HTP-1 was isolated from H.trimaculatus based on our previous work12. Dulbecco’s modified eagle medium 
(DMEM), penicillin/streptomycin, fetal bovine serum (FBS) and the other materials required for culturing cells were 
purchased from Gibco BRL, Life Technologies (Grand Island, NY). Aβ42, Horse serum, nerve growth factor  (NGF), 
Griess reagent, poly-D-lysine, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), transforming 
growth factor-β (TGF-β), TGF-β inhibitor (SB431542), PI3K inhibitor (LY294002), Hoecst 33342, propidium 
iodide (PI) were purchased from Sigma (St. Louis, MO). TRIzol® RNA extraction was provided by Invitrogen Ltd. 
(Paisley, UK). RT-PCR reagents were purchased from Promega (Madison, WI). Specific antibodies used for western 
blot analysis were purchased from Santa Cruz Biotechnology Inc. (Santa Cruz, CA) and Amersham Pharmacia 
Biosciences (Piscataway, NJ). Other chemical and reagents used in this study were of analytical grade.  
2.2. Cell culture, co-culture and assessment of cell viability 
    BV2 cell was a kind gift of Prof. Il Whan Choi (Inje University, Korea). PC12 cell was obtained from American 
Type Culture Collection (Manassas, USA). BV2 cells were grown in DMEM supplemented with 5 % FBS; 
meanwhile PC12 cells were grown in DMEM supplemented with 10 % horse serum and 5 % FBS. For the co-culture 
of microglia and PC12 cells, microglia were first seeded onto cell culture inserts. After overnight incubation, 
microglia were left untreated or exposed Aβ42 in the presence or absence of peptides for 24 h. Afterwards, microglial 
cells were co-culture with PC12 cells by transferring culture inserts containing microglia into PC12 cell monolayers. 
Cell viability was determined by MTT assay as described by Hansen et al. and Rajapakseet al.13,14.  
2.3. Flow cytometric analysis for apoptosis determination (PI-Annexin V method) 
    A combined staining with fluorescence in isothyanateconjugated annexin-V and PI was performed according to 
the method described by Vermes et al.15 with slight modifications.  
2.4. Hoecst/PI double staining 
    The phase contrast image of stimulated PC12 cells were collected using Leica inverted microscope (DM IRB) 
with 40 × objective and a digital CCD camera (CTR 6000; Leica, Wetzlar, Germany) under fluorescence. Cell death 
was determined by propidium iodide (PI) and Hoechst 33258 double fluorescent staining.  
2.5. NO production assay and enzyme immuno assay of PGE2, TNF-α, IL-6 and IL-1β 
    NO levels in the culture supernatants were measured by the Griess reaction as described earlier16. Assesment of 
PGE2, TNF-α, IL-6 and IL-1β synthesis was performed by enzyme immunoassay without prior extraction or 
purification using commercially available enzyme immunometric assay kit (R&D Systems Inc, Minneapolis, USA).  
2.6. Semiquantitative Reverse Transcription Polymerase Chain Reaction (RT-PCR) 
    Total RNA was extracted from BV2 cells treated with Aβ42 in the presence or absence of bioactive peptides using 
TRIzol® reagent. Single stranded cDNA was amplified by PCR with specific primers. The resulting cDNA were 
separated by electrophoresis on 1 % agarose gel for 15 min at 100 V, followed visualization under UV light. Band 
intensities were quantifies with Multi gauge Software (Fujifilm Life Science, Tokyo, Japan). 
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2.7. Western blot analysis 
    Cell lysates were separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) gel 
electrophoresis and electro-blotted onto a nitrocellulose membrane. The membrane were blocked with 5 % bovine 
serum albumin and the incubated with different antibodies which were used to detect respective proteins using a 
chemiluminescent assay kit. Western blots were visualized using a LAS3000® Luminescent image analyzer and 
protein expression was quantified by Multi gauge V3.0 software. 
2.8. Statistical analysis 
 The data were presented as means ± SD (n = 3). Differences between the means of the individual groups were 
assessed by one-way ANOVA with Duncan’s multiple range tests. Differences were considered significant at p < 
0.05. The statistical software package, SPSS v.16 (SPSS Inc., Chicago, Illinois, USA), was used for the analysis. 
3. Results 
3.1. Effect of HTP-1 on BV2 cell viability 
    Cellular compatibility of HTP-1 was tested at three concentrations (10 μM to 100 μM) using MTT cell viability 
assay in BV2 cells. HTP-1 did not show a significant toxic effect on BV2 cells (p < 0.05) (Fig. 2). These data 
suggest that HTP-1 could be used in further experiments safely as it does not have effect on cell proliferation in BV2 
cells and non-toxic concentrations ranging from 10 μM to 100 μM were selected for further analysis. 
 
Fig. 2. Effect of HTP-1 on BV2 cell viability. Viability of cells was quantified as a percentage compared to non-treated group.                            
Values correspond to mean ± SD from three independent experiments. 
3.2. Effects of HTP-1 on Aβ42-induced neurotoxic responses in BV2 cell 
    As shown in Figure 3a, HTP-1 was shown to inhibit NO production which varied dependently upon 
concentration. NO levels upon treatment with 10 μM, 50 μM and 100 μM of HTP-1 were 16.05 μM ± 1.75 μM, 
13.27 μM ± 1.81 μM, and 10.17 μM ± 2.06 μM, respectively.  
    The amount of PGE2 released by BV2 cells was measured using ELISA (Fig. 3b). Obviously, 100 μM of HTP-1 
showed higher inhibitory activity compared to other concentrations (283.2 pg · mL–1 ± 25.46 pg · mL–1). In the next 
step, effect of HTP-1 on the production of pro-inflammatory cytokines (TNF-α, IL-6 and IL-1β) are investigated. As 
shown in Fig. 3c and 3e, at a concentration of 100 μM, HTP-1 exhibited the best effect for the inhibition of TNF-α 
and IL-1β expressions. However, HTP-1 did not show significant inhibition on IL-6 production (Fig. 3b). 
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Fig. 3   Effects of HTP-1 on pro-inflammatory cytokines level in BV2 cells. (a) the amounts of NO were determined using Griess reagent;     
     (b)  the amounts of PGE2;(c) TNF-α;(d) IL-6;(e) IL-1βwere measured by ELISA. Values correspond to mean ± SD from three 
independent experiments. a-e letter in each sample are different significantly by Duncan's multiple range test (p < 0.05). 
3.3. Effects of HTP-1 on microglial neurotoxic mediators mediated PC12 cell death 
    The results showed that when BV2 cells incubated with Aβ42, these cells induced a profound neurotoxicity in 
PC12 cells, which strongly suggest the presence of neuron damaging factors released by BV2. BV2 cells which 
stimulated with Aβ42 markedly reduced the cell viability of PC12 cells (53.19 % ± 1.5 %). The PC12 cell viability 
upon treatment with 100 μM of HTP-1 for 48 h was 82.49 % ± 3.05 %. HTP-1 appears to be effective in protecting 
PC12 cells from BV2 neurotoxicity (Fig. 4). 
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Fig. 4. Neuroprotective effects of HTP-1 in PC12 co-culture with Aβ42-stimulated BV2 cells. Values correspond to mean ± SD from three 
independent experiments. The different letters in each sample are significantly different (p < 0.05) by Duncan's multiple range test.      
 When cells undergo apoptosis, phosphatidylserine is exposed to the surface of the cell and can be detected by 
fluorescent-labelled annexin V. In this study, protective effect of HTP-1 on BV2 microglia-mediated Aβ42 induced 
apoptosis in PC12 cells was monitored by annexinV-FITC apoptosis assay (Fig. 5). The Aβ42 (1 mM) treatment for 
24 h significantly increased the apoptotic PC12 cell population, compared to the vehicle-treated blank group. The 
HTP-1 treatment (10 μM, 50 μM, and 100 μM) significantly reduced the apoptotic cell population in a 
concentration-dependent manner. 
 
 
Fig. 5.Detection of PI-Annexin V staining by FACS in PC12 cells co-culture with Aβ42-stimulated BV2 cells. Except (a) blank and (b) control,   
       cells were pre-treated with HTP-1 at concentration of (c) 10μM, (d) 50 μM,(e) and 100 μM; and then exposed to Aβ42 (5 μM) for 48 h. 
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    The merged images of Hoecst and PI are given for clarity of the results. The intensity reduction of Hoecst-PI 
fluorescence level ensures the protective effect of HTP-1 on PC12 cells survival (Fig. 6). 
 
 
 
Fig. 6.   Micrographs showing fluorescence of apoptotic and dead cells in PC12 cells co-culture with Aβ42-stimulated BV2 cells.  Except blank 
and control cells pre-treated with HTP-1 at concentration of 10μM, 50 μM, and 100 μM, and then exposed to Aβ42 (5 μM) for 48 h 
3.4. Effects of HTP-1 on PC12 cell survival through PI3K/Akt signaling pathway 
    To understand the intracellular signaling mechanism responsible for the protection of HTP-1 against Aβ42-induced 
microglia mediated PC12 cell death, we first chose to test whether phosphatidylinositol 3 kinase (PI3K)/Akt 
pathway is involved. HTP-1 was able to induce the expression of TGF-β in PC12 cells (Fig. 7a). The results 
indicated that there was a significant increase in the PI3K and phosphorylation of Akt in co-culture PC12 cells after 
treated with HTP-1. As shown in Fig. 7b, when HTP-1 was added, it maintained PI3K and phospho-Akt (p-Akt) 
expression levels. Further, PI3K intracellular signaling networks have been demonstrated to activate nuclear factor-
kappa B (NF-κB) and implicated in cell survival. Co-culture of PC12 cells with microglia-stimulated with Aβ42 
resulted in the activation of NF-κB nuclear content, p50 and p65 (Fig.7c). 
 
 
 
 
Fig. 7. Effects of HTP-1 on (a) TGF-β protein expression; (b) PI3K pathway; (c) NF-κB signalling pathway in PC12 co-culture with Aβ42-
induced BV2 cells. The protein expression was measured by western blot analysis. β-tubulin was used as an internal control. 
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3.5. Effects of HTP-1 on pro-survival gene and protein expression 
    It has been reported that Akt activation enhances the expression of pro–survival protein B-cell lymphoma 2 (Bcl-
2), B-cell lymphoma extra-large (Bcl-xL), and X-linked inhibitor of apoptosis protein (XIAP) which prevent cell 
death induced by a variety of toxic insults. As shown in Fig. 8, cells treated with HTP-1 increased the expression 
level of pro-survival protein. As HTP-1 could activate Akt via PI3K, it presumed that up-regulation of Bcl-2, Bcl-xL 
and XIAP by HTP-1 may be contributed to the neuroprotective effect. 
 
Fig. 8. Effects of HTP-1 on pro-survival gene and protein expression in PC12 co-culture with Aβ42-induced BV2 cells.                                 
The mRNA and protein expressions were measured by (a) PCR) and (b) western blot analysis, respectively. 
3.6. Effects of HTP-1 on pro-apoptotic gene and protein expression 
    The protective effect of HTP-1 implies the possibility that HTP-1 might modify pro-apoptotic protein expression 
in PC12 cells. Therefore, the changing expression of Bcl-2-associated X protein (Bax) and Bcl-2-associated death 
promoter (Bad) were determined to see whether these cell death-associated proteins might be also responsible for 
neuroprotective effect of HTP-1. Figure 9 shows that HTP-1 counteracted Aβ42-induced down-regulation of Bax and 
Bad protein expression in PC12 cells.  
 
 
 
Fig. 9. Effects of HTP-1 on pro-apoptotic gene and protein expression in PC12 co-culture with Aβ42-induced BV2 cells.                                
The mRNA and protein expressions were measured by (a) RT-PCR and (b) western blot analysis, respectively. 
3.7. Effects of HTP-1 on cell survival were mediated through TGF-β induced PI3K/Akt signaling pathway 
    To confirm the involvement of TGF-β in PI3K/Akt signaling pathway, the TGF-β inhibitor SB431542 was used. 
The results indicated that SB431542 thoroughly abolished HTP-1 and TGF-β induced PI3K and phosphorylation of 
Akt (Fig. 10a). These result suggested that HTP-1 mediated protection against microglia mediated Aβ42-induced 
apoptosis involves the activation of the PI3K/Akt pathway. Furthermore, the TGF-β induced up-regulation of Bcl-2 
was reduced by LY294002 (PI3K inhibitor), indicating that Bcl-2 was another substrate of Akt contributing to the 
HTP-1 mediated neuroprotection against microglia mediated Aβ42-induced PC12 cell death. However, Bad 
expression was not down regulated by TGF-β, suggesting that inhibitory effect of HTP-1 on Bad expression was 
mediated through other signaling pathway (Fig. 10b).   
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Fig.10. (a) Effects of TGF-β, HTP-1 and SB431542 (TGF-β inhibitor) on PI3K pathway in PC12 co-culture with Aβ4-induced BV2 cells; 
                  (b) Effects of TGF-β, HTP-1 and LY294002 (PI3Kinhibitor) on Bcl-2 and Bad expression in PC12 co-culture with Aβ42-                       
induced BV2 cells. 
4. Discussion 
    Removal of Aβ42 by activated microglia may be beneficial, however, pathological microglia activation is believed 
to contribute to progressive damage in AD through the release of neurotoxic mediators which can cause neuronal 
death17,18. Hence, it is important to unravel mechanisms regulating microglia-induced neuronal death to provide 
insights into efficient therapeutic intervention. The present study showed neuroprotective action of HTP-1 against 
Aβ42 which can be considered through two different mechanisms. The first mechanism was found via attenuation of 
neurotoxic mediators released by BV2 cells. The other mechanism was found through the activation of PI3K/Akt 
signaling pathway in PC12 cells.  
    In fact, microglial overactivation is an early pathogenic event that precedes neutropil destruction in patients with 
AD where Aβ42 induced microglia to release neurotoxic factors19,20. As an example, high levels of NO cause 
oxidative/nitrosative stress to neuronal cells can in turn induced apoptosis by diverse mechanisms, including: 
induction of p53, activation of mitochondrial permeability transition to cause cytochrome c release, and activation of 
the p38 or other MAPK pathways22,23. The present study showed that Aβ42 stimulation results in the production of a 
number of neurotoxic mediators. Importantly, HTP-1 treatment attenuates these Aβ42-mediated neurotoxic responses 
in BV2 cells which provide further insight into potent neuroprotective effects of HTP-1 in PC12 cells. Prevention of 
neuronal death has been introduced as a new therapeutic strategy for neurodegenerative disorders. One of the major 
intracellular signaling pathways for neuron survival is kinase-survival pathway24. HTP-1 induces the activation of 
PI3K/Akt signaling pathway in PC12 neuronal cells. Further, Akt induce NF-κB mediated neuroprotection by its 
ability induce pro-survival gene expression. A variety of mammalian cells are dependent on growth factors for their 
survival. Certain growth factors may also confer protection against apoptosis by stimulating PI3K and/or a 
downstream effector, the Akt kinase25. The present study showed that TGF-β are the activator of PI3K/Akt signaling 
pathway. Since activation of PI3K/Akt signaling pathway was blocked by SB431542 (TGF-β inhibitor) in the 
presence of HTP-1, suggesting that the activity in PC12 cells against Aβ42-induced BV2 mediated apoptosis 
involves the activation of the PI3K/Akt pathway by TGF-β. The neuroprotective effect of TGF-β in vitro has been 
related to its ability to maintain the mitochondrial membrane potential, to stabilize Ca2+ homeostasis, increase the 
expression of the pro-survival proteins, inhibit caspase activation, and induce plasminogen activator inhibitor117. 
Yamaguchi et al.26 reported that Akt, also promotes survival in hippocampal neurons by inhibiting the activity of the 
tumor suppressor p53. Active p53 is known to induce the expression of pro-apoptotic genes and protein, including 
the pro-apoptotic Bcl-2 family member Bax and Bad. p53 activity was recently shown to be critical in controlling 
sympathetic neuronal death following deprivation of NGF27.  
    Several studies indicated that the ability of peptide to show neuroprotective activity is closely related to their 
structure. First, there should be three hydrophobic amino acids; second, the peptide should include polarized amino 
acids at one or both ends in order to increase its solubility; and the peptide should be between 3 and 15 amino acids 
long, with a molecular weight below 1 kDa28. The HTP-1 fulfills all of neuroprotective peptides structure. In 
conclusion, HTP-1 is a potent neuroprotective peptides and could be introduced for the preparation of functional 
ingredients in pharmaceuticals and nutraceuticals as a good approach for the treatment and or prevention of 
neurodegenerative disease particularly AD.  
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